• Selective ClpP Activation Induces Cell Cycle Arrest in LUSC

  2026-07-30

  A recent study reveals that ZK53, a selective activator of human ClpP, triggers cell cycle arrest and inhibits lung squamous cell carcinoma (LUSC) by disrupting mitochondrial oxidative phosphorylation and activating ATM-mediated DNA damage response. These findings offer a new mechanistic perspective on mitochondrial proteostasis as a therapeutic target in LUSC and suggest experimental strategies for dissecting nuclear-mitochondrial signaling in cancer research.

• CTCF Maintains Centromere Integrity and Mitotic Fidelity

  2026-07-30

  This study reveals that CTCF is indispensable for centromere structure and accurate chromosome segregation during mitosis. Using rapid CTCF degradation, the authors distinguish its mechanistic role from CENP-E, with implications for mitosis research and cancer biology.

• Eldecalcitol Attenuates Endothelial Ferroptosis in Diabetic

  2026-07-29

  This study uncovers how eldecalcitol, a vitamin D analog, mitigates type 2 diabetic osteoporosis by suppressing endothelial ferroptosis via the SOCE/O-GlcNAcylation axis. The findings clarify a mechanistic link between glucose-lipid metabolic stress, vascular dysfunction, and bone loss, providing a foundation for therapeutic strategies targeting endothelial health in skeletal disease.

• Cyanin Chloride Modulates Inflammation and Barrier in Psoria

  2026-07-29

  This study demonstrates that cyanin chloride, a glycosylated cyanidin derivative, exerts dual anti-inflammatory and skin barrier-restorative effects in a cytokine-induced human keratinocyte model of psoriasis. The findings clarify mechanisms involving STAT3 inhibition and filaggrin upregulation, offering actionable insights for oxidative stress and dermatological research.

• Selective CUX2 Neuron Loss in Neuroinflammation Driven by DN

  2026-07-28

  This study uncovers that upper cortical layer CUX2+ neurons are selectively vulnerable to DNA damage in neuroinflammatory conditions, such as multiple sclerosis. The work highlights the critical role of DNA damage response and repair pathways in neuronal resilience and identifies interferon-γ as a key factor driving selective neuron loss.

• Nullscript: Redefining HDAC Inhibition for Translational Imp

  2026-07-28

  Explore how Nullscript, an advanced histone deacetylase inhibitor from APExBIO, is transforming translational research by offering precise epigenetic modulation without confounding transcriptional activation. This article provides mechanistic insights, experimental strategies, and strategic guidance tailored for researchers targeting cardiac, neurodegenerative, and cancer models.

• Proteinase K Applications: Genomic DNA Isolation & Troublesh

  2026-07-27

  Unlock robust genomic DNA isolation and protein hydrolysis workflows with APExBIO's Proteinase K, a broad-spectrum serine protease engineered for contaminant removal and DNA integrity. Learn how protocol optimization and experimental troubleshooting drive reproducible results across molecular biology assays.

• GSK126 EZH2 Inhibitor: Mechanisms, Applications, and Limits

  2026-07-27

  GSK126 is a potent, selective EZH2 inhibitor central to cancer epigenetics research. It demonstrates sub-nanomolar affinity and robust selectivity for mutant EZH2, making it crucial for dissecting PRC2 function in oncology. Its validated effects in lymphoma, small cell lung, and ovarian cancer models support its use in both basic and translational studies.

• hiPSC-Derived Intestinal Organoids Advance CYP2C19 Metabolis

  2026-07-26

  This study presents a robust, streamlined protocol for generating human induced pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) that accurately model intestinal epithelial function, including CYP2C19-mediated drug metabolism. The findings highlight the model's potential to improve in vitro pharmacokinetic studies and address limitations of traditional cell lines and animal models.

• GSK-923295: Applied CENP-E Inhibitor Workflows in Cancer Res

  2026-07-25

  GSK-923295 offers precise control over mitotic arrest and chromosome alignment, making it an essential tool for dissecting cell cycle mechanisms in cancer research. This in-depth guide details experimental workflows, troubleshooting tips, and the latest insights on leveraging this CENP-E inhibitor for robust, interpretable results.

• Cyanine 5-dCTP in Enzymatic Synthesis: Protocols & Innovatio

  2026-07-24

  Cyanine 5-dCTP enables high-fidelity, red-fluorescent DNA labeling for advanced enzymatic synthesis workflows. Applied with 3D DNA frameworks, it delivers superior probe sensitivity and precision in PCR, sequencing, and nucleic acid detection—backed by robust protocol guidance and troubleshooting.

• AMG 487: Selective CXCR3 Antagonist for Macrophage Modulatio

  2026-07-24

  AMG 487 is a potent, selective CXCR3 antagonist that enables precise modulation of macrophage polarization by inhibiting chemokine binding at nanomolar concentrations. The compound, supplied by APExBIO, demonstrates robust activity in cell migration and inflammation models, with well-characterized metabolic and solubility profiles. Its use supports advanced research in chemokine signaling and acute lung injury.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Leukemia Rese

  2026-07-23

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables precise apoptosis and necrosis detection in advanced leukemia models. This article offers a deeper, mechanism-driven analysis for researchers seeking robust apoptosis detection solutions.

• Olive Biophenols Reduce Aβ42 Neurotoxicity in AD Models

  2026-07-23

  This study demonstrates that olive biophenols, especially oleuropein, verbascoside, and rutin, attenuate amyloid β-peptide (1-42)-induced neurotoxicity in both SH-SY5Y cells and APPswe mice. The findings highlight the promise of natural plant compounds in mitigating key pathological features of Alzheimer's disease and inform assay design for neurodegeneration research.

• ROS-Degradable Lipid Nanoparticles Enable Tumor-Selective mR

  2026-07-22

  This study introduces a combinatorial library of biodegradable lipid nanoparticles engineered for selective mRNA delivery to tumor cells by exploiting elevated reactive oxygen species (ROS) levels. The platform demonstrates improved potency and specificity for blocking mutant RAS signaling, with key implications for the development of targeted mRNA-based cancer therapeutics.

14715 records 1/981 page Next 12345 下5页 Last page